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In recent years, numerous nuclear receptor-interacting proteins have been identified that influence nuclear
transcription through their direct modification of chromatin. Along with coactivators that possess histone
acetyltransferase (HAT) or methyltransferase activity, other coactivators that lack recognizable
chromatin-modifying activity have been discovered whose mechanism of action is largely unknown.The
presence of multiple protein-protein interaction motifs within mechanistically undefined coactivators suggests
that they function as adaptor molecules, either recruiting or stabilizing promoter-specific protein complexes.
This perspective will focus on a family of nuclear receptor coactivators (i.e., group III LIM domain proteins
related to paxillin) that appear to provide a scaffold to stabilize receptor interactions with chromatin-modifying
coregulators.
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Group III LIM domain proteins
Hic-5 and its closely related family member, paxillin [Kasai
et al., 2003], are nuclear receptor coactivators that lack
histone acetyltransferase (HAT) or methyltransferase
activity.These proteins are members of the group III LIM
domain containing family of proteins, which are
characterized by their localization to both focal adhesions
and within the nucleus [Dawid et al., 1998]. Along with
four carboxyl-terminal LIM domains, Hic-5 also has four
LD motifs within its amino terminus. LIM proteins are well
recognized for their roles as molecular adaptors,
functioning to stabilize higher order protein complexes at
focal adhesion complexes [Dawid et al., 1998] (See Figure
1).Within focal adhesion complexes, Hic-5 as well as
paxillin links various intracellular signaling modules to
plasma membrane receptors that respond to extracellular
signals including growth factors and the extracellular
matrix [Nishiya et al., 1998]. For example, Hic-5 and
paxillin interact with multiple focal adhesion-associated
proteins such as vinculin and focal adhesion kinase (FAK)
[Thomas et al., 1999].
While much work on Hic-5 has focused on its action at
focal adhesions, yeast two hybrid screens revealed the
association of this protein with the androgen receptor
(AR), the glucocorticoid receptor (GR), and peroxisome
proliferator-activated receptor gamma (PPARγ) [Fujimoto
et al., 1999;Yang et al., 2000]. In fact, the ability of Hic-5
to function as an AR coactivator led to its alternative
naming as ARA55.The tau2 transactivation domain of
GR has been delineated as a minimal Hic-5/ARA55
interaction region, but Hic-5/ARA55 binding domains of
AR and PPARγ have only been broadly localized to
receptor ligand binding domains [Drori et al., 2005;
Fujimoto et al., 1999;Yang et al., 2000]. Furthermore, in
addition to various nuclear receptors, Hic-5/ARA55 also
interacts with other transcription factors such as SP-1
and Smad3, upregulating or inhibiting their transcriptional
activation properties, respectively [Shibanuma et al.,
2004;Wang et al., 2005].
Hic-5/ARA55 adaptor function
Recent work from our laboratory has revealed the
mechanism responsible for Hic-5/ARA55 coactivation of
GR [Heitzer and DeFranco, 2006]. In the A1-2 derivative
of T47D breast cancer cells which possess an integrated
mouse mammary tumor virus (MMTV) promoter, single
and sequential chromatin immunoprecipitation (ChIP)
assays revealed an association of Hic-5/ARA55 with GR
and various coactivators on the MMTV as well as p21
and c-fos promoters. Because Hic-5/ARA55 does not
possess HAT or methyltransferase activity, it most likely
does not modify histones directly. However, Hic-5/ARA55
may be involved in recruiting other chromatin modifying
coactivators. In fact, sequential ChIPs revealed that
Hic-5/ARA55 interacts with TIF-2, RAC3, CBP, and p300
coactivators at glucocorticoid responsive promoters
[Heitzer and DeFranco, 2006]. Although Hic-5/ARA55 is
only one of several coactivators that associates with the
glucocorticoid-regulated MMTV promoter in A1-2 cells,
its ablation severely limits glucocorticoid induction of this
viral promoter and an endogenous
glucocorticoid-regulated gene (i.e., p21). However,
Hic-5/ARA55 ablation does not effect glucocorticoid
induction of the c-fos gene in A1-2 cells, demonstrating
selectivity of Hic-5/ARA55 effects. Furthermore, after
siRNA-mediated ablation of Hic-5/ARA55,
ligand-dependent TIF-2 and p300 recruitment to the
MMTV promoter was reduced.Thus, Hic-5/ARA55 has
a role in maintaining the assembly of coactivator
complexes required for efficient glucocorticoid-induced
transcription at the MMTV promoter. Hic-5/ARA55 may
function as an adaptor protein, recruiting or stabilizing
HAT-containing complexes at steroid responsive
promoters (Figure 1).The corresponding reduction of GR
transactivation and coactivator recruitment that results
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Perspective  Nuclear Receptor Signaling  |  The Open Access Journal of the Nuclear Receptor Signaling AtlasFigure 1.  Hic-5-containing complexes at focal adhesions and in the nucleus At focal adhesion complexes, Hic-5/ARA55 interacts with multiple
proteins such as focal adhesion kinase (FAK) and Src, thereby functioning as an adaptor molecule that coordinates multiple protein-protein interactions.
Similarly, in the nucleus, Hic-5/ARA55 serves as an adaptor coregulator, interacting with coactivator containing complexes on nuclear receptor target
promoters.
from partial Hic-5/ARA55 ablation demonstrates the
critical role of Hic-5/ARA55 in maintaining the assembly
of coactivator complexes required to bring about efficient
glucocorticoid-induced transcription.
Hic-5/ARA55-NCoR interactions
Hic-5/ARA55 not only interacts with various coactivator
complexes, but it also associates with NCoR-containing
corepressor complexes in the absence of hormone at
nuclear receptor-responsive promoters [Heitzer and
DeFranco, 2006].This suggests that Hic-5/ARA55 is
capable of directly interacting with other coregulators and
not necessarily via nuclear receptors. Furthermore,
because Hic-5/ARA55 is present on GR-responsive
promoters in the absence and presence of glucocorticoids
[Heitzer and DeFranco, 2006], it may function in
coordinating corepressor release and coactivator
recruitment upon glucocorticoid stimulation.
Although Hic-5/ARA55 was localized to GR-responsive
promoters in the absence of ligand and detectable
promoter-bound GR, the mechanism by which
Hic-5/ARA55 is bound to the promoter in the apparent
absence of the receptor is unclear. In addition to
receptor-independent binding of Hic-5/ARA55 to the
MMTV promoter, we also detected receptor-independent
localization of NCoR to the MMTV promoter in the
absence of ligand [Heitzer and DeFranco, 2006]. Direct
binding of either Hic-5/ARA55 or NCoR to the MMTV
promoter has not been analyzed.
Interestingly, Hic-5/ARA55 does display zinc-dependent
DNA binding [Nishiya et al., 1998]. However, a specific
DNA sequence for which Hic-5/ARA55 is capable of
binding has yet to be identified. If Hic-5/ARA55 is capable
of directly binding the MMTV promoter, it may function in
tethering the NCoR-containing complex to the MMTV
promoter in the absence of ligand. However, it is also
possible that both Hic-5/ARA55 and NCoR are binding
the MMTV promoter through another, yet unidentified
DNA binding protein.
Recently, transducin β-like 1 (TBL1), an adaptor-like
protein, has been reported to mediate the exchange of
corepressors for coactivators on nuclear
receptor-responsive promoters in response to ligand
[Perissi et al., 2004].TBL1 was initially isolated as part
of the NCoR corepressor complex [Li et al., 2000]. ChIP
analysis of nuclear receptor target promoters revealed
prolonged TBL1 promoter association in the presence of
ligand [Perissi et al., 2004]. Furthermore, TBL1 recruited
components of the proteosome machinery to nuclear
receptor target promoters, leading to degradation of the
corepressor complex followed by association of the
coactivator complex [Perissi et al., 2004]. However,
interactions between Hic-5/ARA55 and components of
the proteosome machinery have not yet been analyzed.
Regulation of Hic-5/ARA55 and paxillin
activity and subcellular localization
In addition to Hic-5/ARA55, other members of the group
III LIM domain containing family such as Trip6, and zyxin,
also function in the nucleus [Kadrmas and Beckerle, 2004;
Kassel et al., 2004; Nix et al., 2001], but a detailed
understanding of their function in these contexts remains
undefined. Furthermore, it is unclear whether the nuclear
activity of group III LIM domain proteins is regulated under
any physiological or pathophysiological conditions.
Although regulation of Hic-5/ARA55 and paxillin
coactivator activities has yet to be analyzed, both
Hic-5/ARA55 and paxillin are differentially phosphorylated
by FAK, Pyk2 and Fyn downstream of various growth
factor and integrin signaling pathways [Ishino et al., 2000;
Nishiya et al., 2001]. Future analysis may illustrate subtle
requirements for group III LIM domain-containing protein
activation as well as subcellular localization.
Although many LIM domain containing proteins have
been detected in the nucleus and at focal adhesions and
their nuclear export sequences have been identified, the
precise signals that induce their translocation are mostly
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LIM domain containing AR coactivator, translocates to
the nucleus in response to activation of Rho, a small
GTPase [Labalette et al., 2004; Muller et al., 2000].
Furthermore, it has been reported that nuclear
accumulation of Hic-5/ARA55 occurs in response to
oxidants such as H2O2 [Shibanuma et al., 2003].
Deciphering the signals which are responsible for
Hic-5/ARA55 activation and/or subcellular trafficking may
highlight a putative role for Hic-5/ARA55 in mediating
signals originating from plasma membrane-associated
focal adhesion complexes to the nucleus, thereby
affecting gene expression driven by nuclear receptors.
Hic-5/ARA55 tissue distribution
Although regulatory mechanisms governing Hic-5/ARA55
and paxillin action are largely unknown, analysis of their
limited tissue distribution illustrates yet another unique
feature of this family of nuclear receptor coactivators. For
example, selective expression of Hic-5/ARA55 in smooth
muscle and myoepithelial cells has been revealed by
immunohistochemistry [Yuminamochi et al., 2003].
Hic-5/ARA55 was not detected in epithelial cells of the
tissues examined, including the stomach, colon, liver,
skin, and mammary gland, whereas paxillin was
[Yuminamochi et al., 2003]. Additionally, within an
individual organ, Hic-5/ARA55 and paxillin are expressed
in a cell-type specific manner. For example, in the
prostate, Hic-5/ARA55 is localized to the stromal, while
paxillin is largely found within the epithelial compartment
[Li et al., 2002] (and unpublished results).
Thus, this unique family of nuclear receptor coactivators
including Hic-5/ARA55 and paxillin, may act as “adaptors”
or scaffolds at distinct compartments in the cell (i.e. focal
adhesions and the nucleus) regulating multiple signal
pathways in a cell type-specific manner at sites both
proximal and distal to the initiating signal.
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